CN113121595A - 一种α-R烷氧基对氯苄基膦酸单酯 - Google Patents
一种α-R烷氧基对氯苄基膦酸单酯 Download PDFInfo
- Publication number
- CN113121595A CN113121595A CN201911389704.1A CN201911389704A CN113121595A CN 113121595 A CN113121595 A CN 113121595A CN 201911389704 A CN201911389704 A CN 201911389704A CN 113121595 A CN113121595 A CN 113121595A
- Authority
- CN
- China
- Prior art keywords
- alkoxy
- chlorobenzyl
- phosphonate monoester
- alpha
- preparing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- -1 alkoxy p-chlorobenzyl phosphonate Chemical compound 0.000 title claims abstract description 51
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 15
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 12
- 125000000753 cycloalkyl group Chemical group 0.000 claims abstract description 10
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims abstract description 5
- 229910001413 alkali metal ion Inorganic materials 0.000 claims abstract description 5
- 229910001420 alkaline earth metal ion Inorganic materials 0.000 claims abstract description 5
- 125000003342 alkenyl group Chemical group 0.000 claims abstract description 5
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 18
- 239000003153 chemical reaction reagent Substances 0.000 claims description 16
- 238000006467 substitution reaction Methods 0.000 claims description 16
- 238000006243 chemical reaction Methods 0.000 claims description 12
- AVPYQKSLYISFPO-UHFFFAOYSA-N 4-chlorobenzaldehyde Chemical compound ClC1=CC=C(C=O)C=C1 AVPYQKSLYISFPO-UHFFFAOYSA-N 0.000 claims description 8
- 150000001875 compounds Chemical class 0.000 claims description 8
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 claims description 7
- 150000008301 phosphite esters Chemical class 0.000 claims description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 4
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 claims description 4
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 claims description 4
- 239000003513 alkali Substances 0.000 claims description 4
- RDHPKYGYEGBMSE-UHFFFAOYSA-N bromoethane Chemical compound CCBr RDHPKYGYEGBMSE-UHFFFAOYSA-N 0.000 claims description 4
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 claims description 4
- 238000010534 nucleophilic substitution reaction Methods 0.000 claims description 4
- JYVLIDXNZAXMDK-UHFFFAOYSA-N pentan-2-ol Chemical compound CCCC(C)O JYVLIDXNZAXMDK-UHFFFAOYSA-N 0.000 claims description 4
- AQIXEPGDORPWBJ-UHFFFAOYSA-N pentan-3-ol Chemical compound CCC(O)CC AQIXEPGDORPWBJ-UHFFFAOYSA-N 0.000 claims description 4
- DENRZWYUOJLTMF-UHFFFAOYSA-N diethyl sulfate Chemical compound CCOS(=O)(=O)OCC DENRZWYUOJLTMF-UHFFFAOYSA-N 0.000 claims description 3
- 229940008406 diethyl sulfate Drugs 0.000 claims description 3
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical group COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 claims description 3
- CYNYIHKIEHGYOZ-UHFFFAOYSA-N 1-bromopropane Chemical compound CCCBr CYNYIHKIEHGYOZ-UHFFFAOYSA-N 0.000 claims description 2
- NCTCZGRRDXIGIY-UHFFFAOYSA-N 1-methylcyclopropan-1-ol Chemical compound CC1(O)CC1 NCTCZGRRDXIGIY-UHFFFAOYSA-N 0.000 claims description 2
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 claims description 2
- 229940073608 benzyl chloride Drugs 0.000 claims description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 2
- KTHXBEHDVMTNOH-UHFFFAOYSA-N cyclobutanol Chemical compound OC1CCC1 KTHXBEHDVMTNOH-UHFFFAOYSA-N 0.000 claims description 2
- YOXHCYXIAVIFCZ-UHFFFAOYSA-N cyclopropanol Chemical compound OC1CC1 YOXHCYXIAVIFCZ-UHFFFAOYSA-N 0.000 claims description 2
- 230000006203 ethylation Effects 0.000 claims description 2
- 238000006200 ethylation reaction Methods 0.000 claims description 2
- 229910052736 halogen Inorganic materials 0.000 claims description 2
- 150000002367 halogens Chemical group 0.000 claims description 2
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 claims description 2
- 230000011987 methylation Effects 0.000 claims description 2
- 238000007069 methylation reaction Methods 0.000 claims description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- OJMIONKXNSYLSR-UHFFFAOYSA-N phosphorous acid Chemical compound OP(O)O OJMIONKXNSYLSR-UHFFFAOYSA-N 0.000 claims description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 2
- 230000006207 propylation Effects 0.000 claims description 2
- 238000007127 saponification reaction Methods 0.000 claims description 2
- ISIJQEHRDSCQIU-UHFFFAOYSA-N tert-butyl 2,7-diazaspiro[4.5]decane-7-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCCC11CNCC1 ISIJQEHRDSCQIU-UHFFFAOYSA-N 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 5
- 238000000034 method Methods 0.000 abstract description 8
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Substances CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 abstract description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 8
- 229910052708 sodium Inorganic materials 0.000 description 8
- 239000011734 sodium Substances 0.000 description 8
- 239000012452 mother liquor Substances 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- UFNOUKDBUJZYDE-UHFFFAOYSA-N 2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol Chemical compound C1=NC=NN1CC(O)(C=1C=CC(Cl)=CC=1)C(C)C1CC1 UFNOUKDBUJZYDE-UHFFFAOYSA-N 0.000 description 5
- 239000005757 Cyproconazole Substances 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- ANLFRXGAWNYDEJ-UHFFFAOYSA-L disodium;ethyl phosphate Chemical compound [Na+].[Na+].CCOP([O-])([O-])=O ANLFRXGAWNYDEJ-UHFFFAOYSA-L 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- LRWCURGZPQWMRG-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-cyclopropylpropan-1-one Chemical compound C=1C=C(Cl)C=CC=1C(=O)C(C)C1CC1 LRWCURGZPQWMRG-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- MBTOOKBKBYXTCE-UHFFFAOYSA-L disodium;methyl phosphate Chemical compound [Na+].[Na+].COP([O-])([O-])=O MBTOOKBKBYXTCE-UHFFFAOYSA-L 0.000 description 2
- 238000002329 infrared spectrum Methods 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 125000006414 CCl Chemical group ClC* 0.000 description 1
- XYYXUMPHZWGNSV-UHFFFAOYSA-N C[NH3+].C[NH3+].C[NH3+].[O-]P([O-])([O-])=O Chemical compound C[NH3+].C[NH3+].C[NH3+].[O-]P([O-])([O-])=O XYYXUMPHZWGNSV-UHFFFAOYSA-N 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 238000003889 chemical engineering Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000017858 demethylation Effects 0.000 description 1
- 238000010520 demethylation reaction Methods 0.000 description 1
- DTOMFYCTRINWHW-UHFFFAOYSA-N diazanium;methyl phosphate Chemical compound [NH4+].[NH4+].COP([O-])([O-])=O DTOMFYCTRINWHW-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4056—Esters of arylalkanephosphonic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4071—Esters thereof the ester moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4075—Esters with hydroxyalkyl compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4071—Esters thereof the ester moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4081—Esters with cycloaliphatic alcohols
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
Abstract
Description
技术领域
本发明属于精细化工技术领域,具体涉及一种α-R烷氧基对氯苄基膦酸单酯。
背景技术
环唑醇是瑞士山德公司(Sandoz AG)开发的三唑类杀菌剂,是麦角甾醇脱甲基化抑制剂,具有预防和治疗的作用,广泛应用于西欧和北美。1-(4-氯苯基)-2-环丙基-1-丙酮是合成环唑醇的必须中间体,现有的环唑醇合成工艺都经由其制备。现有的1-(4-氯苯基)-2-环丙基-1-丙酮主要由α-烷氧基对氯苄基膦酸酯制得,如专利CN 2016106712615中记载了一种α-烷氧基对氯苄基膦酸酯的制备方法,其结构式为通过其公开的方法,得到的最终产物百分含量为最高可达95.3%,总收率为最高可达88.3%,总体品质不高,采用该中间体制备1-(4-氯苯基)-2-环丙基-1-丙酮的纯度和收率相对不高,进而影响环唑醇的品质,因此需要研发制备1-(4-氯苯基)-2-环丙基-1-丙酮的新的中间体,以改善目前产品纯度低、收率不高的问题。
发明内容
发明目的:本发明目的在于针对现有技术的不足,提供一种新型的用于制备1-(4-氯苯基)-2-环丙基-1-丙酮的中间体α-R烷氧基对氯苄基膦酸单酯;
本发明的另一目的是提供上述α-R烷氧基对氯苄基膦酸单酯的方法;
本发明的第三目的是提供上述α-R烷氧基对氯苄基膦酸单酯在制备药物组合物中的应用。
技术方案:本发明所述一种α-R烷氧基对氯苄基膦酸单酯,结构式如式(I)所示:
其中:R1选自-(C5-C8)的烷基、-(C3-C8)的环烷基或-(C2-C8)的链烯基;R2选自-(C1-C5)的烷基、或-(C3-C6)的环烷基;
M为H或与碱金属离子或碱土金属离子或有机铵阳离子。
进一步地,作为优选方案,所述R1选自被一个或者多个卤素、氰基或硝基取代的-(C1-C8)的烷基。
本发明还提供了上述α-R烷氧基对氯苄基膦酸单酯的制备方法,包括如下步骤:
(1)三氯化磷与有机醇R2OH通过亲核取代制得亚磷酸酯;
(2)将步骤(1)中制得的亚磷酸酯与碱进行皂化反应生成亚磷酸单酯;
(3)将步骤(2)所得亚磷酸单酯与对氯苯甲醛反应制得式(II)所示化合物;
(4)将步骤(3)中式(II)所示化合物与R1取代试剂进行亲核取代反应,最终制得式(I)化合物α-R烷氧基对氯苄基膦酸单酯;
具体反应式如下:
其中:R1选自-(C5-C8)的烷基、-(C3-C8)的环烷基或-(C2-C8)的链烯基;R2选自-(C1-C5)的烷基、或-(C3-C6)的环烷基;
M为H或与碱金属离子或碱土金属离子或有机铵阳离子。
进一步地,作为优选方案,步骤(1)中有机醇为甲醇、乙醇、丙醇、异丙醇、正丁醇、异丁醇、叔丁醇、1-戊醇、2-戊醇、3-戊醇、环丙醇、环丁醇或1-甲基环丙醇等醇中的一种。
进一步地,作为优选方案,所述步骤(1)中三氯化磷与有机醇R2OH的投料摩尔比为1:3~20;步骤(2)中亚磷酸酯与碱的投料摩尔比为1:1~3;步骤(3)中亚磷酸单酯与对氯苯甲醛的投料摩尔比为1:0.7~1.5;步骤(4)中式(II)所示化合物与取代试剂的投料摩尔比为1:1~2。
进一步地,作为优选方案,步骤(4)所述R1取代试剂包括甲基化取代试剂、乙基化取代试剂、丙基化取代试剂或苄基取代试剂等。
进一步地,作为优选方案,所述R1取代试剂为硫酸二甲酯、硫酸二乙酯、溴乙烷、溴丙烷或氯苄。
有益效果:(1)本发明提供了一种全新的用于制备1-(4-氯苯基)-2-环丙基-1-丙酮的中间体α-R烷氧基对氯苄基膦酸单酯,并且提供了该中间体的制备方法,通过本方法制备的α-R烷氧基对氯苄基膦酸单酯纯度可达98.9%,收率可达94.7%,用于制备1-(4-氯苯基)-2-环丙基-1-丙酮大大提高了其纯度和收率,进而提高了环唑醇的品质。
附图说明
图1为实施例1中制得的α-R甲氧基对氯苄基膦酸单酯钠核磁共振图;
图2为实施例1中制得α-R甲氧基对氯苄基膦酸单酯钠质谱图;
图3为实施例1中制得α-R甲氧基对氯苄基膦酸单酯钠红外谱图。
具体实施方式
下面通过附图对本发明技术方案进行详细说明,但是本发明的保护范围不局限于所述实施例。
实施例1:α-R甲氧基对氯苄基膦酸单乙酯钠的制备
(1)向250ml的四口瓶中投入三氯化磷68.7g(0.5mol)、乙醇161.2g(3.5mol),开启搅拌,在负压、温度为15℃下反应3h;升温至60℃,滴加30%氢氧化钠,监测物料pH=7-8,滴加结束,升温至80℃保温3h;反应结束后,将温度升高至90℃去除多余的乙醇,将剩余母液冷却、离心烘干制得磷酸单乙酯钠62.7g(0.47mol),含量99.3%,收率94%;
(2)向500mL的四口烧瓶中依次投入步骤(1)制得的磷酸单乙酯钠62.7g(0.47mol)、对氯苯甲醛53.41g(0.38mol)、氢氧化钠24g(0.6mol),二氯乙烷150mL,开启搅拌,将温度调节在20-30℃,滴加硫酸二甲酯63.06g(0.5mol),滴加结束后,将温度升高至50℃,保温2h。反应结束后,将温度升高至100℃去除多余的二氯乙烷,将剩余母液冷却、洗涤、抽滤、干燥得到白色粉末状产品α-R甲氧基对氯苄基膦酸单乙酯钠103.24g(0.36mol),含量98.9%,收率94.7%,测其熔点为193.2℃。
图1为本实施例制得的α-R甲氧基对氯苄基膦酸单乙酯钠溶解于D2O中测得的核磁共振图,由谱图可知,在δ=7.447(ppm)(td,2H,-Ph2),δ=7.402(ppm)(td,2H,-Ph3),δ=4.483(ppm)(d,1H,-CH’-P),δ=3.867(ppm)(m,2H,-OCH2’CH3),δ=3.319(ppm)(s,3H,-OCH3’),δ=1.208(ppm)(t,3H,-OCH2CH3’),均出现α-R甲氧基对氯苄基膦酸单乙酯钠的特征峰,证明该方法成功合成了α-R甲氧基对氯苄基膦酸单乙酯钠。
图2为本实施例制得的α-R甲氧基对氯苄基膦酸单乙酯钠溶解于D2O中测得的高效质谱图+PESI-Ms,由谱图可知,测得m/z=287.01,理论值为286.65,证明该方法成功合成了α-R甲氧基对氯苄基膦酸单乙酯钠。
图3为本实施例制得的α-R甲氧基对氯苄基膦酸单乙酯钠测得的傅里叶红外光谱图,由谱图可知,在λ=1457.9-1654.7(C=C),1200P=O)1090.58(P-O-C),841.59(C-P),572.85(C-Cl),均出现α-R甲氧基对氯苄基膦酸单乙酯钠的红外特征吸收峰,证明该方法成功合成了α-R甲氧基对氯苄基膦酸单乙酯钠。
实施例2:α-R乙氧基对氯苄基膦酸单乙酯钠的制备
向500mL的四口烧瓶中依次投入实施例1步骤(1)制得的磷酸单乙酯钠62.7g(0.47mol)、对氯苯甲醛53.41g(0.38mol)、氢氧化钠24g(0.6mol),二氯乙烷150mL,开启搅拌,将温度调节在20-40℃,滴加硫酸二乙酯72.38g(0.5mol),滴加结束后,将温度升高至60℃,保温2h。反应结束后,将温度升高至100℃去除多余的二氯乙烷,将剩余母液冷却、洗涤、抽滤、干燥得到白色粉末状产品α-R乙氧基对氯苄基膦酸单乙酯钠105.2g(0.35mol),含量98.2%,收率92.1%。
实施例3:α-R乙氧基对氯苄基膦酸单甲酯钠的制备
(1)向250ml的四口瓶中投入三氯化磷68.7g(0.5mol)、甲醇118.4g(3.7mol),开启搅拌,在负压、温度为10℃下反应3h;升温至60℃,滴加30%氢氧化钠,监测物料pH=7-8,滴加结束,升温至80℃保温3h;反应结束后,将温度升高至80℃去除多余的甲醇,将剩余母液冷却、离心烘干制得磷酸单甲酯钠55.45g(0.47mol),含量98.7%,收率93.7%。
(2)向500mL的四口烧瓶中依次投入步骤(1)制得的磷酸单甲酯钠55.45g(0.47mol)、对氯苯甲醛53.41g(0.38mol)、氢氧化钠24g(0.6mol),甲苯120mL,开启搅拌,将温度调节在20-30℃,滴加溴乙烷54.9g(0.5mol),滴加结束后,将温度升高至70℃,保温2h。反应结束后,将温度升高至120℃去除多余的甲苯,将剩余母液冷却、洗涤、抽滤、干燥得到白色粉末状产品α-R乙氧基对氯苄基膦酸单甲酯钠102.7g(0.36mol),含量98.6%,收率94.5%。
实施例4:α-R乙氧基对氯苄基膦酸单甲酯铵的制备
(1)向250ml的四口瓶中投入三氯化磷68.7g(0.5mol)、甲醇120g(3.7mol),开启搅拌,在负压、温度为10℃下反应3h;降温至60℃,滴加25%氨水,监测物料pH=7-8,滴加结束,升温至60℃保温3h;反应结束后,将温度升高至80℃去除多余的甲醇,将剩余母液冷却、离心烘干制得磷酸单甲酯铵51.98g(0.46mol),含量99.5%,收率92.3%。
(2)向500mL的四口烧瓶中依次投入步骤(1)制得的磷酸单甲酯铵51.98g(0.46mol)、对氯苯甲醛53.41g(0.38mol)、25%氨水34g(0.5mol),二氯乙烷150mL,开启搅拌,将温度调节在20-30℃,滴加溴乙烷54.9g(0.5mol),滴加结束后,将温度升高至70℃,保温2h。反应结束后,将温度升高至100℃去除多余的二氯乙烷,将剩余母液冷却、洗涤、抽滤、干燥得到白色粉末状产品α-R乙氧基对氯苄基膦酸单甲酯铵99.6g(0.35mol),含量98.8%,收率93.2%。
如上所述,尽管参照特定的优选实施例已经表示和表述了本发明,但其不得解释为对本发明自身的限制。在不脱离所附权利要求定义的本发明的精神和范围前提下,可对其在形式上和细节上作出各种变化。
Claims (7)
2.一种权利要求1所述α-R烷氧基对氯苄基膦酸单酯,其特征在于:所述R1选自被一个或者多个卤素、氰基或硝基取代的-(C1-C8)的烷基。
3.一种权利要求1或2所述α-R烷氧基对氯苄基膦酸单酯的制备方法,其特征在于包括如下步骤:
(1)三氯化磷与有机醇R2OH通过亲核取代制得亚磷酸酯;
(2)将步骤(1)中制得的亚磷酸酯与碱进行皂化反应生成亚磷酸单酯;
(3)将步骤(2)所得亚磷酸单酯与对氯苯甲醛反应制得式(II)所示化合物;
(4)将步骤(3)中式(II)所示化合物与R1取代试剂进行亲核取代反应,最终制得式(I)化合物α-R烷氧基对氯苄基膦酸单酯;
具体反应式如下:
其中:R1选自-(C5-C8)的烷基、-(C3-C8)的环烷基或-(C2-C8)的链烯基;
R2选自-(C1-C5)的烷基、或-(C3-C6)的环烷基;
M为H或与碱金属离子或碱土金属离子或有机铵阳离子。
4.根据权利要求3所述的α-R烷氧基对氯苄基膦酸单酯的制备方法,其特征在于:步骤(1)中有机醇为甲醇、乙醇、丙醇、异丙醇、正丁醇、异丁醇、叔丁醇、1-戊醇、2-戊醇、3-戊醇、环丙醇、环丁醇或1-甲基环丙醇等醇中的一种。
5.根据权利要求3所述的α-R烷氧基对氯苄基膦酸单酯的制备方法,其特征在于:所述步骤(1)中三氯化磷与有机醇R2OH的投料摩尔比为1:3~20;步骤(2)中亚磷酸酯与碱的投料摩尔比为1:1~3;步骤(3)中亚磷酸单酯与对氯苯甲醛的投料摩尔比为1:0.7~1.5;步骤(4)中式(II)所示化合物与取代试剂的投料摩尔比为1:1~2。
6.根据权利要求5所述的α-R烷氧基对氯苄基膦酸单酯的制备方法,其特征在于:步骤(4)所述R1取代试剂包括甲基化取代试剂、乙基化取代试剂、丙基化取代试剂或苄基取代试剂等。
7.根据权利要求6所述的α-R烷氧基对氯苄基膦酸单酯的制备方法,其特征在于:所述R1取代试剂为硫酸二甲酯、硫酸二乙酯、溴乙烷、溴丙烷或氯苄。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911389704.1A CN113121595A (zh) | 2019-12-30 | 2019-12-30 | 一种α-R烷氧基对氯苄基膦酸单酯 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911389704.1A CN113121595A (zh) | 2019-12-30 | 2019-12-30 | 一种α-R烷氧基对氯苄基膦酸单酯 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113121595A true CN113121595A (zh) | 2021-07-16 |
Family
ID=76767373
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911389704.1A Pending CN113121595A (zh) | 2019-12-30 | 2019-12-30 | 一种α-R烷氧基对氯苄基膦酸单酯 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113121595A (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4272448A (en) * | 1978-03-24 | 1981-06-09 | Philagro | Process for the manufacture of aluminum monoethyl phosphite |
CN102942465A (zh) * | 2012-11-22 | 2013-02-27 | 江苏澄扬作物科技有限公司 | 1-(4-氯苯基)-2-环丙基-1-丙酮的制备方法及其中间体 |
CN106187726A (zh) * | 2016-07-05 | 2016-12-07 | 盐城辉煌化工有限公司 | 一种1‑(4‑氯苯基)‑2‑环丙基‑1‑丙酮的合成方法 |
CN106279264A (zh) * | 2016-08-16 | 2017-01-04 | 江苏七洲绿色化工股份有限公司 | 一种α‑烷氧基对氯苄基膦酸酯的制备方法 |
-
2019
- 2019-12-30 CN CN201911389704.1A patent/CN113121595A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4272448A (en) * | 1978-03-24 | 1981-06-09 | Philagro | Process for the manufacture of aluminum monoethyl phosphite |
CN102942465A (zh) * | 2012-11-22 | 2013-02-27 | 江苏澄扬作物科技有限公司 | 1-(4-氯苯基)-2-环丙基-1-丙酮的制备方法及其中间体 |
CN106187726A (zh) * | 2016-07-05 | 2016-12-07 | 盐城辉煌化工有限公司 | 一种1‑(4‑氯苯基)‑2‑环丙基‑1‑丙酮的合成方法 |
CN106279264A (zh) * | 2016-08-16 | 2017-01-04 | 江苏七洲绿色化工股份有限公司 | 一种α‑烷氧基对氯苄基膦酸酯的制备方法 |
Non-Patent Citations (4)
Title |
---|
MICHAEL E. JUNG ET AL: "Total Synthesis of (±)-Kellermanoldione: Stepwise Cycloaddition of a Functionalized Diene and Allenoate", 《ORGANIC LETTERS》 * |
TAO WANG ET AL: "SIMPLE AND IMPROVED PREPARATION OF α-OXOPHOSPHONATE MONOLITHIUM SALTS", 《PHOSPHORUS, SULFUR, AND SILICON》 * |
TOMIOKA, HIDEO ET AL: "Effect of the phosphonate group on the reactivity of carbenes. Neighboring phosphonate group participation", 《JOURNAL OF THE CHEMICAL SOCIETY, CHEMICAL COMMUNICATIONS》 * |
赵立立: "STN检索记录", 《STN检索记录》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002006279A9 (en) | Efficient method of synthesizing combretastatin a-4 prodrugs | |
CN101624403A (zh) | 磷氮型季铵盐及其制备方法和应用 | |
DK149609B (da) | Analogifremgangsmaade til fremstilling af hydroxyamino-alkan- eller -alkenphosphonsyrederivater eller estere eller salte deraf | |
US20100063313A1 (en) | Method for producing phosphorus-containing alpha-keto acid | |
CN105073749A (zh) | 制备利拉利汀的改进方法 | |
RU2013114370A (ru) | Производные эфиров фосфоновых кислот и способы их синтеза | |
JP3980065B2 (ja) | ジアルキルホスフィン酸アルミニウムの製造方法 | |
WO2022242540A1 (zh) | 一种三配位磷衍生物及中间体及制备方法 | |
CN113121595A (zh) | 一种α-R烷氧基对氯苄基膦酸单酯 | |
JP2019052139A (ja) | 7α−アルコキシオキサセフェム中間体の製造方法 | |
US4427599A (en) | Method for preparation of N-phosphonomethylglycine | |
JP4035642B2 (ja) | リン酸2,5―ジオキソ―4,4―ジフェニル―イミダゾリジン―1―イルメチル エステルのジエステル合成の改良された方法 | |
JPH1045783A (ja) | ヒドロキシクロマン誘導体リン酸エステルの製造方法 | |
WO2009093258A2 (en) | A new and improved process for the preparation of ibandronate sodium monohydrate | |
JPH02174789A (ja) | リボフラビン―4’,5’―シクロ燐酸エステルクロリド、ならびにリボフラビン―5’―ホスファート(5’―fmn)もしくはそのナトリウム塩の製法 | |
KR101134021B1 (ko) | 새로운 중간체를 이용하는 피타바스타틴 헤미칼슘의 신규한 제조방법 | |
SU739076A1 (ru) | Способ получени -аминоэтилидендифосфоновых кислот | |
JPS643191B2 (zh) | ||
US3350481A (en) | Monoesters of phosphonic acids | |
EP0295576B1 (en) | Process for the production of the derivatives of 1,3,2-oxazaphosphorinane | |
KR102137340B1 (ko) | Eob-dtpa의 신규 제조방법 | |
CN104650143B (zh) | 制备福沙匹坦二甲葡胺中间体的方法 | |
JPH03279390A (ja) | N―アルキル置換アミノメチルホスホン酸誘導体の製造方法 | |
KR101195631B1 (ko) | 9-[2-(포스포노메톡시)에틸]아데닌의 개선된 제조방법 | |
US9422228B2 (en) | Process for the preparation of optically pure fesoterodine derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210716 |